Longboard looks like an intriguing play within the biotech sector. The company was spun out of Arena Pharmaceuticals in 2020 - Arena was subsequently acquired by Pfizer in a $6.7bn deal. Arena's lead ...
Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback